Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Dehydroxyhispolon Methyl Ether, A Hispolon Derivative, Inhibits WNT/β-Catenin Signaling to Elicit Human Colorectal Carcinoma Cell Apoptosis

HC. Fan, YC. Hsieh, LH. Li, CC. Chang, K. Janoušková, MV. Ramani, GV. Subbaraju, KT. Cheng, CC. Chang

. 2020 ; 21 (22) : . [pub] 20201122

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019805

Grantová podpora
TTMHH-108R0010 Tungs' Taichung MetroHarbor Hospital

Colorectal cancer (CRC) is the fourth leading cause of cancer mortality worldwide. Aberrant activation of WNT/β-catenin signaling present in the vast majority of CRC cases is indispensable for CRC initiation and progression, and thus is a promising target for CRC therapeutics. Hispolon is a fungal-derived polyphenol with a pronounced anticancer effect. Several hispolon derivatives, including dehydroxyhispolon methyl ether (DHME), have been chemically synthesized for developing lead molecules with stronger anticancer activity. Herein, a DHME-elicited anti-CRC effect with the underlying mechanism is reported for the first time. Specifically, DHME was found to be more cytotoxic than hispolon against a panel of human CRC cell lines, while exerting limited toxicity to normal human colon cell line CCD 841 CoN. Additionally, the cytotoxic effect of DHME appeared to rely on inducing apoptosis. This notion was evidenced by DHME-elicited upregulation of poly (ADP-ribose) polymerase (PARP) cleavage and a cell population positively stained by annexin V, alongside the downregulation of antiapoptotic B-cell lymphoma 2 (BCL-2), whereas the blockade of apoptosis by the pan-caspase inhibitor z-VAD-fmk attenuated DHME-induced cytotoxicity. Further mechanistic inquiry revealed the inhibitory action of DHME on β-catenin-mediated, T-cell factor (TCF)-dependent transcription activity, suggesting that DHME thwarted the aberrantly active WNT/β-catenin signaling in CRC cells. Notably, ectopic expression of a dominant-active β-catenin mutant (∆N90-β-catenin) abolished DHME-induced apoptosis while also restoring BCL-2 expression. Collectively, we identified DHME as a selective proapoptotic agent against CRC cells, exerting more potent cytotoxicity than hispolon, and provoking CRC cell apoptosis via suppression of the WNT/β-catenin signaling axis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019805
003      
CZ-PrNML
005      
20210830101416.0
007      
ta
008      
210728s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21228839 $2 doi
035    __
$a (PubMed)33266494
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Fan, Hueng-Chuen $u Department of Pediatrics, Department of Medical Research, Tungs' Taichung Metroharbor Hospital, Wuchi, Taichung 43503, Taiwan $u Department of Rehabilitation, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 35664, Taiwan $u Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 40227, Taiwan
245    10
$a Dehydroxyhispolon Methyl Ether, A Hispolon Derivative, Inhibits WNT/β-Catenin Signaling to Elicit Human Colorectal Carcinoma Cell Apoptosis / $c HC. Fan, YC. Hsieh, LH. Li, CC. Chang, K. Janoušková, MV. Ramani, GV. Subbaraju, KT. Cheng, CC. Chang
520    9_
$a Colorectal cancer (CRC) is the fourth leading cause of cancer mortality worldwide. Aberrant activation of WNT/β-catenin signaling present in the vast majority of CRC cases is indispensable for CRC initiation and progression, and thus is a promising target for CRC therapeutics. Hispolon is a fungal-derived polyphenol with a pronounced anticancer effect. Several hispolon derivatives, including dehydroxyhispolon methyl ether (DHME), have been chemically synthesized for developing lead molecules with stronger anticancer activity. Herein, a DHME-elicited anti-CRC effect with the underlying mechanism is reported for the first time. Specifically, DHME was found to be more cytotoxic than hispolon against a panel of human CRC cell lines, while exerting limited toxicity to normal human colon cell line CCD 841 CoN. Additionally, the cytotoxic effect of DHME appeared to rely on inducing apoptosis. This notion was evidenced by DHME-elicited upregulation of poly (ADP-ribose) polymerase (PARP) cleavage and a cell population positively stained by annexin V, alongside the downregulation of antiapoptotic B-cell lymphoma 2 (BCL-2), whereas the blockade of apoptosis by the pan-caspase inhibitor z-VAD-fmk attenuated DHME-induced cytotoxicity. Further mechanistic inquiry revealed the inhibitory action of DHME on β-catenin-mediated, T-cell factor (TCF)-dependent transcription activity, suggesting that DHME thwarted the aberrantly active WNT/β-catenin signaling in CRC cells. Notably, ectopic expression of a dominant-active β-catenin mutant (∆N90-β-catenin) abolished DHME-induced apoptosis while also restoring BCL-2 expression. Collectively, we identified DHME as a selective proapoptotic agent against CRC cells, exerting more potent cytotoxicity than hispolon, and provoking CRC cell apoptosis via suppression of the WNT/β-catenin signaling axis.
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    12
$a apoptóza $7 D017209
650    _2
$a Basidiomycota $x chemie $7 D001487
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a kolorektální nádory $x farmakoterapie $x metabolismus $x patofyziologie $7 D015179
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a HCT116 buňky $7 D045325
650    _2
$a lidé $7 D006801
650    _2
$a poly(ADP-ribosa)polymerasy $x metabolismus $7 D011065
650    _2
$a protoonkogenní proteiny c-bcl-2 $x genetika $7 D019253
650    _2
$a signální dráha Wnt $x účinky léků $7 D060449
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hsieh, Ya-Chu $u Ph.D. Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung 40227, Taiwan $u Institute of Biomedical Sciences, National Chung Hsing University, Taichung 40227, Taiwan
700    1_
$a Li, Li-Hsuan $u Ph.D. Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung 40227, Taiwan $u Institute of Biomedical Sciences, National Chung Hsing University, Taichung 40227, Taiwan
700    1_
$a Chang, Ching-Chin $u Institute of Biomedical Sciences, National Chung Hsing University, Taichung 40227, Taiwan
700    1_
$a Janoušková, Karolína $u Institute of Biomedical Sciences, National Chung Hsing University, Taichung 40227, Taiwan $u University of Chemistry and Technology, 166 28 Prague, Czech Republic
700    1_
$a Ramani, Modukuri V $u Department of Organic Chemistry, Andhra University, Visakhapatnam 530 003, India
700    1_
$a Subbaraju, Gottumukkala V $u Department of Organic Chemistry, Andhra University, Visakhapatnam 530 003, India
700    1_
$a Cheng, Kur-Ta $u Department of Biochemistry and Molecular Cell Biology, Taipei Medical University, Taipei 11031, Taiwan
700    1_
$a Chang, Chia-Che $u Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 40227, Taiwan $u Ph.D. Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung 40227, Taiwan $u Institute of Biomedical Sciences, National Chung Hsing University, Taichung 40227, Taiwan $u Department of Life Sciences, The iEGG and Animal Biotechnology Research Center, Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung 40227, Taiwan $u Traditional Herbal Medicine Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan $u Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan $u Department of Biotechnology, Asia University, Taichung 41354, Taiwan
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 22 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33266494 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101417 $b ABA008
999    __
$a ok $b bmc $g 1690587 $s 1140251
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 22 $e 20201122 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a TTMHH-108R0010 $p Tungs' Taichung MetroHarbor Hospital
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace